<p><strong>In patients with persistent prostate-related hematuria due to LUTS/BPH, clinicians may offer 5-ARI treatment. (<em>Expert Opinion</em>)</strong></p>
Discussion
Discussion
<p>Administration of 5-ARIs has been demonstrated to reduce the microvascular density in prostatic stroma and, in RCTs, has shown to reduce the amount of perioperative blood loss at TURP.<sup>184</sup> This same mechanism is thought to be clinically useful to treat hematuria from a prostatic source, although its efficacy has only been substantiated in small case series.<sup>185, 186</sup></p>